Introduction: Although circadian variation of (motor) symptoms in Parkinson disease (PD) 
November 2011 and July 2018. Patients were divided into three groups based on their date of assessment, using a simplified seasonal model: group 1: November-February (n=107); group 2: March-15 June (n=107); and group 3: 16 June-October (n=158). Primary outcome was a seasonal difference in NMS scale (NMSS) total scores (higher scores reflecting greater disability). We hypothesized that PD patients exhibit circannual NMS burden patterns.
Results: All groups were identical concerning disease onset and duration, HY stage, Levodopa equivalent dose, and gender. There was a seasonal difference in NMSS total scores (p=0.040), with the highest scores (57.1±42.5) in season 1 (winter months) and the lowest (45.1±34.4) in season 3 (summer months) (p=0.037). Seasonal differences were observed in NMSS domain 1 (cardiovascular symptoms) (p=0.011), domain 4 (perceptual problems) (p=0.017) and domain 9 (miscellaneous symptoms) (p=0.009). A trend was observed for domain 2 (sleep) (p=0.057).
Conclusion: NMS in PD fluctuate throughout the year, with worsening of symptoms in the winter months compared to the summer months suggestive of dysfunction of the body's master clock, the suprachiasmatic nuclei. Such variations must be accommodated in daily care to ascertain appropriate changes in medication regimes and in clinical trials for the interpretation of outcomes.
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Introduction:
Diurnal fluctuations in Parkinson disease (PD) are well-recognised, mainly in relation to motor symptoms. For example, patterns of daily activity differ significantly between patients with PD and healthy elderly people. There is a notable decrease in morning peak activity with flattened overall daily activity, both strongly correlating with disease severity [1, 2] . Responsiveness of motor symptoms to L-dopa treatment also seems to decrease throughout the day, without significant alterations in pharmacokinetics, indicating a possible circadian system involvement [3, 4] . A similarly altered diurnal regulation of non-motor symptoms has also been reported for autonomic functions (blood pressure, heart rate), psychiatric symptoms (hallucinations) and sleep impairment. Specifically, patients with PD may experience a disappearance of circadian rhythmicity in blood pressure regulation manifesting with postprandial hypotension, nocturnal hypertension and increased diurnal blood pressure variability and decreased hearth rate variability [5] [6] [7] [8] [9] [10] [11] . Likewise, 24-hour electrocardiography monitoring revealed loss of circadian heart rate variability, a decrease of sympathetic activity during the day and lack of sympathetic morning peak increase in heart rate as well as a diminished low versus high heart rate frequency ratio reflecting a flattening of circadian modulation [12] [13] [14] . Moreover, circadian disruption in patients with PD experiencing hallucinations is associated with greater intra-daily variability of rest-activity cycles, decreased amplitude of activity and increased night-time activity compared to nonhallucinators [15] .
In clinical practice, we have also observed that the severity of symptoms in PD patients may alter with change of seasons. Symptoms appear to be less pronounced when the climate is warmer in summer months and worse in winter (when there is also less daylight).
However, clear evidence for seasonal fluctuations in PD symptoms is lacking, and only a handful of studies have explored the possibility of circannual fluctuations in PD. In a study
with 546 PD patients, no difference in UPDRS motor scores was observed over the four seasons of the year [16] . In another study determining the seasonal effect on hallucinations, again no effect of the seasons was observed [17] . For other non-motor symptoms, no studies are available. We therefore set out to determine the seasonal effect on non-motor symptoms in PD.
Methods:
In this cross-sectional analysis, all consecutive patients between November 2011 and 
Results:
A total of 372 patients who had a baseline assessment were included: 107 patients were allocated to group 1 (November -February), 107 to group 2 (March -15 June) and 158 to group 3 (16 June -October). All groups were identical concerning disease onset and M A N U S C R I P T A C C E P T E D We performed a separate analysis for domain 9 (miscellaneous) for the separate questions in this domain (pain, smell, weight loss and sweating). This revealed that smell was better in the summer months (16 June -October) compared to the winter (NovemberFebruary) and spring months (March -15 June) (p=0.008 and 0.024, respectively; Table 1 ).
Discussion:
This is the first comprehensive study showing seasonal differences in NMS in PD patients. In line with the subjective impression of patients and health care professionals, we observed significant seasonal differences in NMS in PD patients, with mostly higher scores (i.e. more complaints) during the winter months and lower scores during the summer months.
The change of NMS scores between seasons in patients was determined by changes in the cardiovascular and falls, hallucinations and perceptual problems and miscellaneous domains of the NMSS. A trend was observed for sleep and fatigue. Remarkably, depression scores, which could potentially explain these differences, did not carry with the seasons.
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Seasonal variations in NMS can be accounted for by several factors. A prime factor is the influence of the biological clock located in the suprachiasmatic nuclei (SCN) within the hypothalamus. The involvement of the circadian system in PD has been shown in several studies. For example, decreased expression of melatonergic receptors (MT 1 and MT 2) has been observed in the amygdala and substantia nigra [23] . In addition, circulating melatonin levels are affected in PD patients compared to the healthy elderly population [24, 25] and these changes correspond with a disruption in slow wave and REM sleep [26] . Here, light therapy is a promising strategy to realign circadian output and potentially improve fluctuating (both circadian and seasonal) symptoms [27] [28] [29] .
The role of depression, which is known to fluctuate in severity across seasons, being worse in winter and autumn compared to the other seasons [30] , could explain the differences. Depressed patients might be inclined to answer globally more negative to all questions. In our study group, however, we did not observe a change in depression scores across the different seasons, making it unlikely that fluctuation of depression scores explains the seasonal variations in NMS. The absent fluctuation of depressive symptoms might be related to the use of the HADS which is normally used as a screening tool and not to make a formal diagnosis of depression. In PD, the HADS is not recommended for scoring severity of depressive symptoms [31] . Moreover, a recent study has shown that the depression subsection of the HADS shows an item bias for several items influencing group differences between e.g. age groups [32] . The NMSS is also a global tool for addressing the burden of NMS as a while and includes cognition, dysautonomia, sleep and pain and it is likely that changes could have been missed in this specific domain because of the composite nature of this scale [18, 19] .
The main limitation of the current study relates to the cross-sectional nature (use of single measurements in individual patients), rather than follow-up scores at different times M A N U S C R I P T
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8 during the year within individual patients. Preferably, a similar study should be conducted with several assessments throughout the year within the same patients. We feel, however, that our current results are still meaningful, considering there was no difference between the three groups concerning disease duration, Hoehn and Yahr stages, LEDD and sex which in themselves can also influence NMS burden. It is therefore likely that the observed results are indeed due to seasonal changes.
In conclusion, we observed seasonal differences in total NMS scores in PD patientswith highest scores during the winter months and lower scores during the summer months. • These changes did not coincide with the amount of dopaminergic medication
